Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
30.09
+1.61 (5.65%)
At close: Aug 13, 2025, 4:00 PM
29.41
-0.68 (-2.26%)
Pre-market: Aug 14, 2025, 8:54 AM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 437 employees as of December 31, 2024. The number of employees increased by 147 or 50.69% compared to the previous year.
Employees
437
Change (1Y)
147
Growth (1Y)
50.69%
Revenue / Employee
$3,185
Profits / Employee
-$846,302
Market Cap
2.83B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRNX News
- 2 days ago - Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025 - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025 - GlobeNewsWire